Metabolomic profiling of the effects of allopurinol on Drosophila melanogaster

Metabolomics

Volumn 7, Issue 4, 2011, Pages 542-548

  Bratty, Mohammed Al ^a   Hobani, Yahya ^b   Dow, Julian A T ^b,c   Watson, David G ^a  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Allopurinol; Drosophila; Fourier transform mass spectrometry; Kynurenine pathway; Metabolomics; Oxidative stress; Rosy

Indexed keywords

ALLANTOIN; ALLOPURINOL; ASCORBIC ACID; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTATHIONE; GLUTATHIONE DISULFIDE; HYPOXANTHINE; KYNURENINE; METHIONINE SULFOXIDE; PENTOSE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; RIBOFLAVIN; URIC ACID; XANTHINE;

ANIMAL EXPERIMENT; ARTICLE; ASCORBIC ACID METABOLISM; CONTROLLED STUDY; DROSOPHILA MELANOGASTER; FOURIER TRANSFORM MASS SPECTROMETRY; HYDROPHILIC INTERACTION CHROMATOGRAPHY; METABOLOMICS; MUTATION; NONHUMAN; OXIDATIVE STRESS; TRYPTOPHAN METABOLISM;

DROSOPHILA MELANOGASTER;

EID: 80054016623     PISSN: 15733882     EISSN: 15733890     Source Type: Journal    
DOI: 10.1007/s11306-011-0275-6     Document Type: Article

References (32)

1. Barry, S., Clarke, G., Scully, P., & Dinan, T. G. (2009). Kynurenine pathway in psychosis: Evidence of increased tryptophan degradation. Journal of Psychopharmacology, 23, 287-294.
2. Batabyal, D., & Yeh, S. R. (2007). Human tryptophan dioxygenase: A comparison to indoleamine 2, 3-dioxygenase. Journal of the American Chemical Society, 129, 15690-15701.
3. Botting, N. P. (1995). Chemistry and neurochemistry of the kynurenine pathway of tryptophan metabolism. Chemical Society Reviews, 24, 401-412.
4. Buie, L. W., Oertel, M. D., & Cala, S. O. (2006). Allopurinol as adjuvant therapy in poorly responsive or treatment refractory schizophrenia. Annals of Pharmacotherapy, 40, 2200-2204.
5. Darlington, L. G., Mackay, G. M., Forrest, C. M., Stoy, N., George, C., & Stone, T. W. (2007). Altered kynurenine metabolism correlates with infarct volume in stroke. European Journal of Neuroscience, 26, 2211-2221.
6. Dickerson, F. B., Stallings, C. R., Origoni, A. E., Sullens, A., Khushalani, S., Sandson, N., et al. (2009). A double-blind trial of adjunctive allopurinol for schizophrenia. Schizophrenia Research, 109, 66-69.
7. Dietzel, U., Kuper, J., Doebbler, J. A., Schulte, A., Truglio, J. J., Leimkuhler, S., et al. (2009). Mechanism of substrate and inhibitor binding of rhodobacter capsulatus xanthine dehydrogenase. Journal of Biological Chemistry, 284, 8759-8767.
8. Dow, J. A. T. (2007). Model organisms and molecular genetics for endocrinology. General and Comparative Endocrinology, 153, 3-12.
9. Dow, J. A. T., & Davies, S. A. (2003). Integrative physiology and functional genomics of epithelial function in a genetic model organism. Physiological Reviews, 83, 687-729.
10. Dunn, W. B. (2008). Current trends and future requirements for the mass spectrometric investigation of microbial, mammalian and plant metabolomes. Physical Biology. 5, 011001.
11. Enrico, P., Esposito, G., Mura, M. A., Migheli, R., Serra, P. A., Desole, M. S., et al. (1997). Effects of allopurinol on striatal dopamine, ascorbate and uric acid during an acute morphine challenge: Ex vivo and in vivo studies. Pharmacological Research, 35, 577-585.
12. Glantzounis, G. K., Tsimoyiannis, E. C., Kappas, A. M., & Galaris, D. A. (2005). Uric acid and oxidative stress. Current Pharmaceutical Design, 11, 4145-4151.
13. Glassman, E. (1965). Genetic regulation of xanthine dehydrogenase in Drosophila melanogaster. Federation Proceedings 24, 1243-1251.
14. Hilliker, A. J., Duyf, B., Evans, D., & Phillips, J. P. (1992). Urate-null rosy mutants of Drosophila melanogaster are hypersensitive to oxygen stress. Proceedings of the National Academy of Sciences of the United States of America, 89, 4343-4347.
15. Ille, R., & Nishino, T. (1995). Flavoprotein structure and mechanism 4. Xanthine oxidase and xanthine dehydrogenase. Faseb Journal, 9, 995-1003.
16. Kamleh, M. A., Dow, J. A. T., & Watson, D. G. (2009). Applications of mass spectrometry in metabolomic studies of animal model and invertebrate systems. Briefings in Functional Genomics & Proteomics, 8, 28-48.
17. Kamleh, M. A., Hobani, Y., Dow, J. A. T., & Watson, D. G. (2008). Metabolomic profiling of Drosophila using liquid chromatography Fourier transform mass spectrometry. Febs Letters, 582, 2916-2922.
18. Kim, Y. S., Nam, H. J., Chung, H. Y., Kim, N. D., Ryu, J. H., Lee, W. J., et al. (2001). Role of xanthine dehydrogenase and aging on the innate immune response of Drosophila. Journal of the American Aging Association, 24, 187-193.
19. King, N. J. C., & Thomas, S. R. (2007). Molecules in focus: Indoleamine 2, 3-dioxygenase. International Journal of Biochemistry and Cell Biology, 39, 2167-2172.
20. Krastanov, A. (2010). Metabolomics-the state of the art. Biotechnology & Biotechnological Equipment, 24, 1537-1543.
21. Legan, S. K., Rebrin, I., Mockett, R. J., Radyuk, S. N., Klichko, V. I., Sohal, R. S., et al. (2008). Overexpression of glucose-6-phosphate dehydrogenase extends the life span of Drosophila melanogaster. Journal of Biological Chemistry, 283, 32492-32499.
22. Lotito, S. B., & Frei, B. (2004). The increase in human plasma antioxidant capacity after apple consumption is due to the metabolic effect of fructose on urate, not apple-derived antioxidant flavonoids. Free Radical Biology and Medicine, 37, 251-258.
23. Macchiarulo, A., Camaioni, E., Nuti, R., & Pellicciari, R. (2009). Highlights at the gate of tryptophan catabolism: a review on the mechanisms of activation and regulation of indoleamine 2, 3-dioxygenase (IDO), a novel target in cancer disease. Amino Acids, 37, 219-229.
24. Massie, H. R., Shumway, M. E., & Whitney, S. J. P. (1991). Uric-acid content of Drosophila decreases with aging. Experimental Gerontology, 26, 609-614.
25. Mohamedali, K. A., Guicherit, O. M., Kellems, R. E., & Rudolph, F. B. (1993). The highest levels of purine catabolic enzymes in mice are present in the proximal small intestine. Journal of Biological Chemistry, 268, 23728-23733.
26. Muir, S. W., Harrow, C., Dawson, J., Lees, K. R., Weir, C. J., Sattar, N., et al. (2008). Allopurinol use yields potentially beneficial effects on inflammatory indices in those with recent ischemic stroke a randomized, double-blind, placebo-controlled trial. Stroke, 39, 3303-3307.
27. Pacher, P., Nivorozhkin, A., & Szabo, C. (2006). Therapeutic effects of xanthine oxidase inhibitors: Renaissance half a century after the discovery of allopurinol. Pharmacological Reviews, 58, 87-114.
28. Scalbert, A., Brennan, L., Fiehn, O., Hankemeir, T., Kristal, B. S., et al. (2009). Mass-spectrometry-based metabolomics: limitations and recommendations for future progress with particular focus on nutrition research. Metabolomics, 5, 435-458.
29. Sevanian, A., Davies, K. J. A., & Hochstein, P. (1991). Serum urate as an antioxidant for ascorbic-acid. American Journal of Clinical Nutrition, 54, S1129-S1134.
30. Spagou, K., Tsoukali, H., Raikos, N., Gika, H., Wilson, I. D., & Theodoridis, G. (2010). Hydrophilic interaction chromatography coupled to MS for metabonomic/metabolomic studies. Journal of Separation Science, 33, 716-727.
31. Wigglesworth, V. B. (1939). The principles of insect physiology. London: Methuen.
32. Wilcoxen, K. M., Uehara, T., Myint, K. T., Sato, Y., & Oda, Y. (2010). Practical metabolomics in drug discovery. Expert Opinion on Drug Discovery, 5, 249-263.